Generali Asset Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.11M Buy
57,138
+4,804
+9% +$452K 0.07% 221
2026
Q1
$6.19M Buy
52,334
+12,032
+30% +$1.49M 0.13% 156
2025
Q4
$5.07M Sell
40,302
-14,766
-27% -$1.93M 0.1% 184
2025
Q3
$8.06M Buy
55,068
+2,252
+4% +$340K 0.17% 116
2025
Q2
$8.24M Buy
52,816
+2,562
+5% +$406K 0.19% 115
2025
Q1
$8.27M Sell
50,254
-13,927
-22% -$2.32M 0.2% 109
2024
Q4
$10.5M Buy
+64,181
New +$11.5M 0.27% 78

Other funds holding ZTS

Generali Asset Management's ZTS Position: Q2 2026 in Review

Generali Asset Management increased its Zoetis (ZTS) stake by 9.2% in Q2 2026, buying an estimated $452K and bringing the position to 57,138 shares worth $4.11M. The position accounts for 0.07% of the portfolio, ranked #221.

Generali Asset Management first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.5M in Q4 2024. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Generali Asset Management held 57,138 shares of Zoetis worth $4.11M as of Q2 2026.
  • Generali Asset Management bought 4,804 Zoetis shares in Q2 2026, an estimated $452K.
  • Zoetis made up 0.07% of Generali Asset Management's portfolio in Q2 2026, its #221 holding.
  • Generali Asset Management first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Zoetis position peaked at $10.5M in Q4 2024.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.